2009 - Review Articles

Citations 1-10 of 22 total displayed.

Most recent content (1 Nov 2009):

reviews
Breast carcinoma—rare types: review of the literature

R. Yerushalmi, M. M. Hayes, and K. A. Gelmon
Ann. Onc. 2009; 20: 1763-1770. [Abstract] [Full text] [PDF]  

reviews
Third consensus on medical treatment of metastatic breast cancer

S. Beslija, J. Bonneterre, H. J. Burstein, V. Cocquyt, M. Gnant, V. Heinemann, J. Jassem, W. J. Köstler, M. Krainer, S. Menard, T. Petit, L. Petruzelka, K. Possinger, P. Schmid, E. Stadtmauer, M. Stockler, S. Van Belle, C. Vogel, N. Wilcken, C. Wiltschke, C. C. Zielinski, H. Zwierzina, and for the Central European Cooperative Oncology Group (CECOG)
Ann. Onc. 2009; 20: 1771-1785. [Abstract] [Full text] [PDF]  

Past content (since Jan 2009):

reviews
Cancer and thrombosis: implications of published guidelines for clinical practice

A. A. Khorana
Ann. Onc. 2009; 20: 1619-1630. [Abstract] [Full text] [PDF]  

reviews
Quality assurance for radical hysterectomy for cervical cancer: the view of the European Organization for Research and Treatment of Cancer—Gynecological Cancer Group (EORTC-GCG)

L. Verleye, I. Vergote, N. Reed, and P. B. Ottevanger
Ann. Onc. 2009; 20: 1631-1638. [Abstract] [Full text] [PDF]  

reviews
2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group

P. Debourdeau, D. Kassab Chahmi, G. Le Gal, I. Kriegel, E. Desruennes, M.-C. Douard, I. Elalamy, G. Meyer, P. Mismetti, M. Pavic, M.-L. Scrobohaci, H. Lévesque, J. M. Renaudin, D. Farge, and on behalf of the working group of the SOR
Ann. Onc. 2009; 20: 1459-1471. [Abstract] [Full text] [PDF]  

reviews
Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008

J. I. Cohen, H. Kimura, S. Nakamura, Y.-H. Ko, and E. S. Jaffe
Ann. Onc. 2009; 20: 1472-1482. [Abstract] [Full text] [PDF]  

reviews
HDAC inhibitor-based therapies and haematological malignancy

L. Stimson, V. Wood, O. Khan, S. Fotheringham, and N. B. La Thangue
Ann. Onc. 2009; 20: 1293-1302. [Abstract] [Full text] [PDF]  

reviews
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network

E. Terpos, O. Sezer, P. I. Croucher, R. García-Sanz, M. Boccadoro, J. San Miguel, J. Ashcroft, J. Bladé, M. Cavo, M. Delforge, M.-A. Dimopoulos, T. Facon, M. Macro, A. Waage, and P. Sonneveld
Ann. Onc. 2009; 20: 1303-1317. [Abstract] [Full text] [PDF]  

review
What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer?

C. H. Barrios, C. Sampaio, J. Vinholes, and R. Caponero
Ann. Onc. 2009; 20: 1157-1162. [Abstract] [Full text] [PDF]  

reviews
High-resolution lymphoscintigraphy is essential for recognition of the significance of internal mammary nodes in breast cancer

A. J. Spillane, F. Noushi, R. A. Cooper, V. Gebski, and R. F. Uren
Ann. Onc. 2009; 20: 977-984. [Abstract] [Full text] [PDF]  

[Next page] Pages: 1 2 3